Allergic Conjunctivitis Market

1
(No Transcript)
2
Allergic Conjunctivitis (AC)
It usually happens when a persons eyes come into
contact with an allergen, a substance that makes
the bodys immune system to overreact. The
disease can be acute or chronic.
Allergic Conjunctivitis is a common eye condition
in which the tissue that lines the inside of
eyelid and outside of the eyeball called
conjunctiva, becomes inflamed.
Allergic conjunctivitis is an exclusive term that
encompasses seasonal allergic conjunctivitis
(SAC), perennial allergic conjunctivitis (PAC),
vernal kerato conjunctivitis (VKC), and atopic
kerato conjunctivitis (AKC).
Unlike conjunctivitis that is caused by bacterial
infection, allergic conjunctivitis is not
contagious, so it cannot be transferred from one
person to another.

• DelveInsight 2019 All rights reserved

3
Allergic Conjunctivitis Epidemiology
Allergic Conjunctivitis total diagnosed prevalent
cases were found out to be 65,502,156 in 2017
among 7MM. The highest diagnosed AC prevalent
cases were seen in the United States.
Allergic conjunctivitis can be acute or chronic.
Acute allergic conjunctivitis cases are found to
be more prevalent as compared to the chronic
cases.
AC prevalence
AC PREVALENCE
Allergies conjunctivitis affect people of all
ages, though they are more common in children and
young adults.
AC prevalence
AC PREVALENCE
Allergic Conjunctivitis higher diagnosed
prevalence in the United States was 33,805,769 in
2017 that is expected to increase still 2028.

• DelveInsight 2019 All rights reserved

4
Allergic Conjunctivitis Market
Allergic Conjunctivitis therapeutic market in
seven major markets (7MM) was estimated to be
USD 1617.9 million in 2017 that is expected to
increase by 2028.
Drugs in the clinical trials are expected to
propel the growth of Allergic Conjunctivitis drug
market in the upcoming years.
The United States accounts for the largest
Allergic Conjunctivitis market size in comparison
to EU5 (Germany, France, Italy, Spain, and the
United Kingdom), and Japan.
Extensive research and development activities of
pharmaceutical companies to develop Allergic
Conjunctivitis therapies will create a positive
impact in Allergic Conjunctivitis market during
the forecast period (2019-2028).
Among the EU5 countries, Germany had the highest
market size in 2017, while Spain had the lowest
market size of Allergic Conjunctivitis.
7MM- USA, EU-5(Germany, Spain, Italy, France
and UK), Japan

• DelveInsight 2019 All rights reserved

5
AC Emerging Drugs and Companies
01
Drug- ADX-102 Company- Aldeyra Therapeutics
02
Drug- PRT-2761 Company- ORA, Inc.
03
Drug- OTX-DP Company- Ocular Therapeutix, Inc
04
Drug- Bilastine Company- Faes Farma

• DelveInsight 2019 All rights reserved

6
Complete Information
For complete information on
Allergic Conjunctivitis Market Insights,
Epidemiology Market Forecast-2028 please
click the link below
CLICK HERE
OR
Write Us At 
info_at_delveinsight.com

• DelveInsight 2019 All rights reserved

7
About DelveInsight
1
2
3

• DelveInsight 2019 All rights reserved

8
Services by DelveInsight
PharmDelve
Forecasting
Opportunity Assessment
Consulting
Report Store
Market Intelligence
Competitive Analysis
Pipeline

• DelveInsight 2019 All rights reserved

9
Contact Us
info_at_delveinsight.com
91-11-4568 9769
www.delveinsight.com
blog/delveInsight/
twitter/delveInsight
LinkedIn/delveInsight

• DelveInsight 2019 All rights reserved

10
Pompe Disease
9